INTRODUCTION
Subglottic stenosis (SGS) is a component of laryngotracheal stenosis
that involves the narrowing of the airway below the vocal cords.
Symptoms of SGS include wheezing, dyspnea, hoarseness, stridor, and, in
severe cases, asphyxiation [1,2]. It may be caused by congenital,
acquired, or iatrogenic factors, with acquired cases often attributed to
infection, trauma, or idiopathic causes [3]. In patients with
laryngotracheal stenosis, the most common cause is iatrogenic factors,
accounting for 54.7% of cases, with 59% developing subglottic stenosis
[4]. Autoimmune diseases are one of the less common causes of SGS
and include granulomatosis polyangiitis, relapsing polychondritis,
inflammatory bowel disorders, rheumatoid arthritis, sarcoidosis, and
amyloidosis. A diagnosis of idiopathic SGS is made when there is no
identifiable underlying systemic disease, and it is typically a
diagnosis of exclusion. Despite the availability of effective endoscopic
and open surgical interventions, the inflammatory aspect of the
condition continues to hinder many patients from achieving complete
remission [2]. A detailed medical history is essential for patients
with respiratory issues because misidentifying the condition can lead to
treatment delays and life-threatening consequences.
Our study aimed to report an atypical subglottic stenosis associated
with spondyloarthropathy. While this condition is commonly associated
with various etiologies, such as trauma, iatrogenic factors, or
idiopathic causes, its occurrence in the context of spondyloarthropathy
remains relatively less understood. This case report sheds light on the
importance of early recognition and management to improve the quality of
life of affected individuals.